ACHEM Technology Corporation (referred to as ‘ACHEM’) was established in 1960 and has a history spanning over 60 years. ACHEM’s core competitive advantage lies in coating technology, specializing in the professional production and management of pressure-sensitive adhesive tape products. It is among the first companies in Taiwan to develop and manufacture PVC tapes, earning international acclaim for pioneering BOPP (Biaxially oriented polypropylene) material for sealing tapes. In the manufacturing and coating technology of acrylic pressure-sensitive adhesives, ACHEM holds a distinguished position as one of the world’s leading manufacturers.
Acer Inc.
Acer Inc. was founded in 1976 by Stan Shih and is a Taiwan-based global technology company with operations in over 160 countries. Building on its strong foundation in computing and data technologies, Acer has strategically expanded into the biomedical field to develop a next-generation RNA therapeutics platform. Since 2018, the company has focused on personalized cancer vaccines, powered by proprietary AI models for high-precision neoantigen prediction. This AI-driven engine enables rapid identification of clinically relevant targets, significantly accelerating and improving the design of individualized immunotherapies. In 2021, Acer established its mRNA-LNP platform and has since developed a proprietary ionizable lipid, AIL-111, engineered for high delivery efficiency and favorable in vivo performance. This platform enables robust mRNA delivery and serves as the foundation for multiple therapeutic applications. Leveraging this core capability, Acer is advancing a targeted LNP (tLNP) platform for cell-specific delivery, including in vivo CAR-T cell generation, where mRNA is directly delivered to T cells within the body to induce transient CAR expression. This approach has the potential to simplify manufacturing, reduce cost, and improve accessibility compared to conventional ex vivo cell therapies. By integrating AI-driven antigen discovery, proprietary LNP delivery technology, and in vivo cell engineering, Acer is building a scalable and modular platform for next-generation RNA medicines. The company aims to become a key innovator at the intersection of digital technology and biopharmaceutical development, enabling transformative therapies for cancer and beyond.
Accurate Meditech Inc
Accurate Meditech Inc. has developed a sensor hub that continuously measures blood pressure without requiring an inflatable cuff. In June 2023, it passed the review of the US FDA for the first time and obtained the world’s first OTC cuffless blood pressure monitor. Bringing a new way of monitoring one’s cardiovascular health.
Academia Sinica
Academia Sinica has adopted various measures to promote the internal integration of research activities in its three Divisions (Mathematics and Physical Sciences, Life Sciences, and Humanities and Social Sciences) so as to fulfill the following goals: 1. To enhance the value of research activities by improving the planning, implementation, and evaluation of long-term projects; 2. To harness basic research results for applications and technology transfer; 3. To engage with Taiwan’s academic community in advancing a modern and forward-looking collective scholarly vision; 4. To cultivate an intellectual environment that is conducive to the nurturing of young scholars and the recognition of outstanding scholarship in Taiwan; and, 5. To promote international cooperation and scholarly exchanges that will accelerate the overall development of academic research at Academia Sinica and in the Republic of China. The Biomedical Translation Research Center (BioTReC) was founded in September 2019 at the National Biotechnology Research Park (NBRP) with the aspiration to support the development of biotechnology in Taiwan. The objectives of BioTReC align with government initiatives to accelerate bio-entrepreneurship from early discovery stages to commercialization. The BioTReC foster growth among innovative pharmaceutical businesses via networking and joint-venture opportunities and to provide access to invaluable R&D and marketing resources. In addition to startups and small businesses, we welcome the installation of mature firms. We adhere to the ideal that dynamic interactions within a diversified portfolio foster a productive exchange of insights and experiences, and we look forward to fruitful results in this ecosystem. We also provide space and cooperation schemes for the establishment or extension of internationally leading accelerators, which can maximize the impact of funding from our country’s investors and venture capital funds. Main Services : • Forge a professional and innovative ecosystem that facilitates new drug discovery, as the creation of a thriving biotechnology industry will ultimately enhance the health and welfare of society. • 9 World-Class Core Facilities to accelerate the timeline for translational research and pre-clinical verification of innovative precision by providing researchers with advanced instruments, high-priced equipment, and technical services on disease prevention, detection, diagnosis and treatment. • Incubate 47 companies to push the development of Biologics, Nucleic Acid Drugs & Regenerative Medicine, Smart Healthcare & Precision Medicine, and Botanical Drugs & Small Molecule Drugs: Provide one-stop service to support resident companies during the R&D stage and subsequent product commercialization. Cultivate business talents by constructing training programs on scientific innovation and entrepreneurship. • Solicit the most promising 31 proposals of projects that seek to translate biomedical technologies.-Facilitate industry-oriented innovation and multi-disciplinary collaboration in translational medicine, enhancing the competitiveness of new drug development and medical applications from translational research to clinical use. Business Interests: Translational medical research, Core facility support, Innovation and incubation center, Smart healthcare, Collaborative Bio cluster / Bio park.
Ableman International Co. Ltd.
Established in 1983, ABLEMAN creates high quality and reliable sanitation products. ABLEMAN offer a wide range of products, including touch-free foam soap dispensers, touch-free hand sanitizers, touch-free towel dispensers, auto air fresheners, and touch-free feminine hygiene bins, as well as various hygiene equipment. In 1998, ABLEMAN introduced the world’s first battery powered touch-free spray hand sanitizer. Fast forward to today, having achieved groundbreaking success in the US, EU, and Japan markets. Fully based in Taiwan and serving the international market, ABLEMAN has become a reputable name in the public hygiene industry. From research and design, manufacturing, to quality assurance, sales and after-sales service, ABLEMAN can provide full and comprehensive manufacturing support to clients worldwide. Total hygiene and safety, as well as efficiency and operation over time are the guiding principles of ABLEMAN’s philosophy to establish long-term, trusted relationships with every client and user.
Aavara Innovation Corp.
Aavara® Innovation Corp. delivers specialist AV and IT integration solutions globally. For over 17 years, this Taiwan-based leader has driven success with its core offerings: Cutting-Edge AV-over-IP solutions and Ergonomic Professional Mounting Systems. We empower our global partners with deep AV/IT expertise and unparalleled logistical support, including our EU Logistic Hub (Netherlands) for reliable 3-day European delivery. Aavara actively contributes to the industry through engagement with associations like AVIXA, Dante Ecosystem, HDMI, VESA, and HDCP, ensuring our partners have the resources to win projects across the residential, commercial, corporate, and educational sectors. Choose Aavara for expertise you can trust.Â
AB DigiHealth Inc.
AB DigiHealth Inc. stands as a pioneering, modern core laboratory dedicated to advancing genomic research. Originating as a startup from Center for Genomic Medicine, National Cheng Kung University in Taiwan, our mission is to bridge the gap between scientific discoveries and clinical applications, providing a comprehensive solution for maternal-fetal precision medicine to the world. Harnessing state-of-the-art Next-Generation Sequencing (NGS) technology, advanced bioinformatics, and AI predictive algorithms, our goal is to usher prenatal genetic testing into a new era. As guardians of maternal-fetal health, we endeavor to create an efficient, empowering digital solution that leverages cloud-based NGS analytics pipelines and AI-based companion diagnosis. Our vision is to establish a next-generation healthcare system characterized by high accuracy, enhancing operational efficiency in laboratories and clinics.
A-MAX ( SMARVO ) Electronics Ltd.
A-MAX (SMARVO) Electronics Ltd. , a 45-Year Professional OEM/ODM Factory in – Wood Cabinets- Amplifiers- Pro Audio- EffectsPlease refer to www.amax-amps.com for experiencing our Professionalism.